Keywords: albunex, approved, europe, hafslund, nycomed, ultrasound, contrast

ALBUNEX APPROVED IN EUROPE

Article | 07 February 1994

Print This

- Hafslund Nycomed's ultrasound contrast agent Albunex has been approved for marketing by the Swedish health authorities - the first in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in